Werken Glorieux
- Address
- Stefaan Modest Glorieuxlaan 55, 9600 Ronse, Belgium
Werken Glorieux - Cardiovascular and Renal Disease Research Center
Werken Glorieux is a specialized clinical research center focused on advancing therapeutic interventions for cardiorenal diseases and lipid metabolism disorders. The center demonstrates particular expertise in conducting large-scale cardiovascular outcomes trials and investigating novel pharmacological approaches to managing chronic conditions affecting the heart, kidneys, and vascular system.
- Chronic kidney disease (CKD) with hypertension and cardiorenal protection strategies
- Atherosclerotic cardiovascular disease (ASCVD) prevention and treatment
- Lipid disorders and lipoprotein(a) targeted therapies
- Cardiovascular outcomes research and primary prevention trials
The center's research portfolio emphasizes evaluating combination therapies for chronic kidney disease progression, including studies of aldosterone synthase inhibitors with SGLT2 inhibitors to prevent kidney function decline and cardiovascular death. Additionally, Werken Glorieux is actively involved in groundbreaking trials investigating RNA interference therapeutics such as inclisiran and olpasiran, targeting elevated cholesterol and lipoprotein(a) levels to reduce major adverse cardiovascular events in both established cardiovascular disease patients and those at risk for first cardiovascular events.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1AstraZeneca AB1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Werken Glorieux
lock Showing 1 of 6 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Baxdrostat and Dapagliflozin on Renal and Cardiovascular Outcomes in Chronic Kidney Disease with Hypertension | AstraZeneca AB | Phase III | Recruiting | May 2025 | — |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baxdrostat | 2 | Unknown | 2024-06-05 | 2025-05-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.